SRRK
Scholar Rock Holding Corporation
NASDAQ · USHealthcareBiotechnology
$50.66-4.16%
Price as of Jul 20, 2026
SRRK profitability
Scholar Rock Holding Corporation profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- —
- EBITDA margin
- —
- EBIT margin
- —
- Net margin
- —
- Free cash flow margin
- —
Returns
- Return on equity
- -148.1%
- Return on assets
- -76.4%
- Return on invested capital
- -85.0%
- Asset turnover
- 0.00x
Cash efficiency
- Cash from operations
- -$303.5M
- Cash per share
- $4.01
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.